Menu
BREAKING NEWS: Trump Announces Deal With AstraZeneca To Offer U.S. 'Most Favored Nation' Prices

BREAKING NEWS: Trump Announces Deal With AstraZeneca To Offer U.S. 'Most Favored Nation' Prices

Forbes Breaking News

46,091 views 9 months ago 7 min read

Video Summary

The administration has announced a significant achievement in lowering prescription drug prices for Americans through an agreement with a major pharmaceutical manufacturer. This deal includes the implementation of a "most favored nation" pricing clause, ensuring that Americans will pay the lowest global price for prescription drugs. This initiative is expected to save taxpayers hundreds of millions of dollars annually and represents a substantial reduction compared to previous efforts.

Furthermore, the company is committed to offering its entire catalog of prescription drugs to Medicaid at these discounted rates. This includes major price reductions, potentially over 100% for some medications like inhalers and certain diabetic drugs, with an average reduction of approximately 654% for specific treatments. All new medications introduced to the market will also be sold at these reduced prices.

In addition to drug price reductions, the manufacturer plans to invest $50 billion in the United States over the next five years for research, development, and the establishment of onshore manufacturing facilities. One new plant, breaking ground in Virginia, is projected to create 3,600 jobs initially. This agreement is being hailed as a historic victory for American patients and the nation's economy, with claims of being the first administration to substantially lower healthcare costs.

Short Highlights

  • A new agreement ensures Americans will pay the lowest global price for prescription drugs through a "most favored nation" pricing clause.
  • This initiative is projected to save American taxpayers hundreds of millions of dollars each year.
  • The pharmaceutical manufacturer will offer all its prescription drugs to Medicaid at the most favored nation's prices.
  • Significant discounts are expected, with some drugs seeing reductions of over 100%, and an average of 654% for specific treatments like inhalers and diabetic medications.
  • The company will invest $50 billion in the U.S. over five years for R&D and manufacturing, creating 3,600 initial jobs at a new Virginia plant.

Key Details

Major Announcements and Economic Relief [0:00]

  • Big announcements are being made, including significant progress in lowering drug prices.
  • Prices for groceries and oil have decreased, with oil breaking $60 a barrel and expected to fall below $2 a gallon soon, about 70% lower than a year ago.
  • Falling oil prices are anticipated to lower the cost of other goods.

This section highlights recent economic improvements, focusing on reduced prices for essential goods like oil and groceries, setting a positive tone for further announcements.

We've gotten prices way down for groceries, for oil, especially today. We broke 60 $60 barrel. They'll be We think the oil is going to be under $2 a gallon very soon. That's about uh 70% lower than what it was just a year ago. So, that's a big thing. And when the oil comes down, everything comes down. It's pretty pretty beautiful to watch.

Pharmaceutical Partnership for Lower Drug Costs [0:46]

  • A major pharmaceutical manufacturer is committing to offer significant discounts on its prescription drugs to Americans.
  • This agreement includes a "most favored nation's pricing" clause.
  • The "most favored nation" pricing means Americans will pay the lowest price available globally for these drugs.
  • This initiative is presented as a continuation of efforts from a previous term, which was interrupted.
  • The goal is to stop Americans from paying a disproportionately high fraction of drug costs compared to other nations.
  • Thanks are extended to the CEO of the pharmaceutical company for their collaboration.
  • Several government officials and a governor are acknowledged for their presence and contributions.

This segment introduces a key partnership aimed at reducing prescription drug expenses, emphasizing the implementation of a global pricing standard for the benefit of American consumers.

Astroenica, the largest pharmaceutical manufacturer in the United Kingdom, is committing to offer Americans major discounts on their vast catalog of prescription drugs. One of the great companies, by the way, and a most favored nation's pricing clause. So, most favored nation is you're going to pay whatever the lowest price anywhere in the world is, that's what you're going to be paying.

Addressing High Prescription Drug Prices [2:18]

  • For many years, Americans have paid the highest prices globally for prescription drugs, often many times more than other countries.
  • An executive order was signed to ensure Americans pay no more for prescription medications than the lowest price in other developing nations.
  • The pharmaceutical company is now committing to offer all its prescription medications to Medicaid at "most favored nations" prices, meaning the lowest global price.
  • This move is expected to save American taxpayers hundreds of millions of dollars annually.
  • In a previous term, a notable achievement was lowering drug prices by 1/8 of 1%, which was the first reduction in 28 years.
  • Current efforts are expected to result in much larger price reductions, ranging from 100% to 1,000% in some cases.
  • These reductions will have a significant positive impact on programs like Social Security, Medicare, and Medicaid.

This section details the historical context of high drug prices in the U.S. and highlights how the new agreement aims to drastically reduce these costs, building on past, albeit smaller, successes.

For many years, Americans have paid the highest prices anywhere in the world for prescription drugs. By far, by far, many times the amount that other countries are paying. Ridiculous.

Manufacturer's Online Listings and Price Reductions [4:04]

  • The manufacturer will list many of its popular drugs online at trumprx.gov.
  • The heavily discounted "most favored nations" cost is expected to provide discounts potentially over 100% in many cases.
  • As an example, a particular drug saw a 654% reduction in price.
  • This applies to inhalers for COPD and asthma, as well as certain diabetic medications.
  • All future medications introduced by the manufacturer to the American market will also be sold at these discounted rates.

This part focuses on the practical implementation of the discounts, including online accessibility and specific examples of significant price reductions for common medications.

As an example one particular drug that's hot very hot 654% on inhalers uh COP PD and asthma as well as certain uh diabetics medications they're going to be averaging about 654% reduction in price.

Investment in U.S. Research, Development, and Manufacturing [5:07]

  • The manufacturer will invest $50 billion in the United States over the next five years.
  • This investment will support research and development of new drugs.
  • It will also fund onshore manufacturing facilities across the country.
  • A new plant in Virginia broke ground recently, with the governor attending.
  • This new facility is expected to create 3,600 jobs initially.
  • This is described as a tremendous victory for Virginia and American patients, marking a significant expansion of the company's presence in the U.S.

This section highlights the substantial economic benefits beyond just lower drug prices, including significant investment in innovation and job creation within the United States.

Furthermore, Astroenica will invest $50 billion dollars in the United States over the next five years for research and development of new drugs into onshore manufacturing facilities across the country like the new plant that broke ground yesterday in Charlottesville, Virginia.

Administration's Success in Lowering Healthcare Costs [5:53]

  • Presidents have promised to lower healthcare costs for years, but this administration claims to be the first to achieve it substantially.
  • The achieved reductions are at numbers previously thought impossible, far exceeding typical percentages like 1% or 2%.
  • The reductions are in the range of 100%, 200%, 300%, 500%, and even 700% in some cases.
  • Major drug companies are collaborating to make these cost reductions a reality.
  • There is anticipation for an upcoming opening of a new facility in a beautiful location.
  • Government officials are invited to speak, followed by a Q&A session.

This concluding part reiterates the administration's claim of being the first to significantly lower healthcare costs, emphasizing the unprecedented scale of the achieved price reductions and the collaborative effort with major pharmaceutical companies.

Presidents have promised for years to lower the cost of healthcare, but my administration is actually the first to do it and do it substantially. You do it at numbers that nobody thought even I thought were not possible.

Other People Also See